GeneThera, Inc. (GTHR)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2022 | - USD | 100.0% |
| 2021 | -0.04 USD | -0.5% |
| 2020 | -0.04 USD | -161.84% |
| 2019 | -0.02 USD | 86.18% |
| 2018 | -0.11 USD | -482.01% |
| 2017 | -0.02 USD | 5.97% |
| 2016 | -0.02 USD | 32.32% |
| 2015 | -0.03 USD | -78.92% |
| 2014 | -0.02 USD | 54.77% |
| 2013 | -0.04 USD | 48.67% |
| 2012 | -0.07 USD | -58.54% |
| 2011 | -0.05 USD | -108.8% |
| 2010 | -0.02 USD | 78.0% |
| 2009 | -0.10 USD | 97.65% |
| 2008 | -4.18 USD | 94.99% |
| 2007 | -83.39 USD | 74.22% |
| 2006 | -323.42 USD | 62.79% |
| 2005 | -869.09 USD | 42.06% |
| 2004 | -1500.07 USD | -117.38% |
| 2003 | -690.06 USD | 68.08% |
| 2002 | -2161.79 USD | 12.17% |
| 2001 | -2461.42 USD | -2992.24% |
| 2000 | -79.60 USD | 92.25% |
| 1999 | -1026.78 USD | -136.59% |
| 1998 | -434.00 USD | -22842005.26% |
| 1997 | -0.00 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 Q1 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2022 Q3 | -0.00 USD | 13.95% |
| 2022 Q1 | -0.00 USD | 60.61% |
| 2022 FY | - USD | 100.0% |
| 2022 Q4 | - USD | 100.0% |
| 2022 Q2 | -0.00 USD | -10.26% |
| 2021 Q3 | -0.01 USD | 26.05% |
| 2021 Q2 | -0.01 USD | -38.37% |
| 2021 Q4 | -0.01 USD | -12.5% |
| 2021 Q1 | -0.01 USD | -28.36% |
| 2021 FY | - USD | -0.5% |
| 2020 Q1 | -0.00 USD | 51.22% |
| 2020 Q2 | -0.01 USD | -37.5% |
| 2020 Q3 | -0.01 USD | -38.18% |
| 2020 Q4 | -0.01 USD | 11.84% |
| 2020 FY | - USD | -161.84% |
| 2019 Q3 | 0.00 USD | 121.95% |
| 2019 Q2 | -0.00 USD | 6.82% |
| 2019 Q1 | -0.00 USD | 95.42% |
| 2019 Q4 | -0.01 USD | -1011.11% |
| 2019 FY | - USD | 86.18% |
| 2018 Q3 | -0.01 USD | 0.0% |
| 2018 Q1 | -0.01 USD | -68.57% |
| 2018 FY | - USD | -482.01% |
| 2018 Q4 | -0.10 USD | -1003.45% |
| 2018 Q2 | -0.01 USD | -47.46% |
| 2017 Q3 | -0.00 USD | 5.26% |
| 2017 FY | - USD | 5.97% |
| 2017 Q1 | -0.01 USD | -1433.33% |
| 2017 Q2 | -0.00 USD | 52.5% |
| 2017 Q4 | -0.00 USD | 2.78% |
| 2016 Q1 | -0.01 USD | -23.29% |
| 2016 FY | - USD | 32.32% |
| 2016 Q4 | 0.00 USD | 109.09% |
| 2016 Q3 | -0.01 USD | -11.86% |
| 2016 Q2 | -0.01 USD | 34.44% |
| 2015 FY | - USD | -78.92% |
| 2015 Q1 | -0.01 USD | -635.71% |
| 2015 Q2 | -0.00 USD | 59.22% |
| 2015 Q3 | -0.01 USD | -95.24% |
| 2015 Q4 | -0.01 USD | 10.98% |
| 2014 Q3 | -0.00 USD | 46.27% |
| 2014 Q1 | -0.01 USD | -23.26% |
| 2014 FY | - USD | 54.77% |
| 2014 Q4 | -0.00 USD | 61.11% |
| 2014 Q2 | -0.01 USD | -26.42% |
| 2013 Q2 | -0.01 USD | 1.87% |
| 2013 FY | - USD | 48.67% |
| 2013 Q4 | -0.00 USD | 63.87% |
| 2013 Q3 | -0.01 USD | -13.33% |
| 2013 Q1 | -0.01 USD | 61.51% |
| 2012 Q1 | -0.02 USD | 58.6% |
| 2012 Q2 | -0.01 USD | 35.27% |
| 2012 FY | - USD | -58.54% |
| 2012 Q4 | -0.03 USD | -186.6% |
| 2012 Q3 | -0.01 USD | 27.61% |
| 2011 FY | - USD | -108.8% |
| 2011 Q1 | -0.01 USD | 19.75% |
| 2011 Q4 | -0.05 USD | 15.68% |
| 2011 Q2 | -0.01 USD | -20.0% |
| 2011 Q3 | -0.06 USD | -660.26% |
| 2010 FY | - USD | 78.0% |
| 2010 Q1 | -0.00 USD | -68.97% |
| 2010 Q2 | -0.00 USD | 18.37% |
| 2010 Q4 | -0.01 USD | -72.34% |
| 2010 Q3 | -0.00 USD | -17.5% |
| 2009 Q1 | -0.12 USD | -113.04% |
| 2009 Q3 | -0.03 USD | -34.41% |
| 2009 Q2 | -0.02 USD | 79.42% |
| 2009 Q4 | -0.00 USD | 91.27% |
| 2009 FY | - USD | 97.65% |
| 2008 Q4 | 0.92 USD | 106.58% |
| 2008 Q2 | -15.58 USD | 12.13% |
| 2008 Q1 | -17.73 USD | -30.85% |
| 2008 Q3 | -13.98 USD | 10.27% |
| 2008 FY | - USD | 94.99% |
| 2007 Q1 | -30.98 USD | 76.52% |
| 2007 FY | - USD | 74.22% |
| 2007 Q4 | -13.55 USD | 27.69% |
| 2007 Q3 | -18.74 USD | 57.41% |
| 2007 Q2 | -44.00 USD | -42.03% |
| 2006 Q3 | -100.00 USD | -23.66% |
| 2006 Q4 | -131.94 USD | -31.94% |
| 2006 FY | - USD | 62.79% |
| 2006 Q1 | -32.71 USD | 79.83% |
| 2006 Q2 | -80.87 USD | -147.23% |
| 2005 FY | - USD | 42.06% |
| 2005 Q1 | -499.99 USD | -119.61% |
| 2005 Q2 | -75.01 USD | 85.0% |
| 2005 Q3 | -179.98 USD | -139.94% |
| 2005 Q4 | -162.18 USD | 9.89% |
| 2004 Q4 | 2550.00 USD | 3588.85% |
| 2004 Q3 | -73.09 USD | 98.26% |
| 2004 Q2 | -4200.55 USD | -611.85% |
| 2004 Q1 | -590.09 USD | -4.61% |
| 2004 FY | - USD | -117.38% |
| 2003 Q1 | -109.80 USD | 84.05% |
| 2003 FY | - USD | 68.08% |
| 2003 Q4 | -564.10 USD | -892.09% |
| 2003 Q3 | -56.86 USD | 80.93% |
| 2003 Q2 | -298.12 USD | -171.51% |
| 2002 Q4 | -688.53 USD | -30.31% |
| 2002 FY | - USD | 12.17% |
| 2002 Q1 | -1012.01 USD | 58.95% |
| 2002 Q2 | -1485.40 USD | -46.78% |
| 2002 Q3 | -528.38 USD | 64.43% |
| 2001 FY | - USD | -2992.24% |
| 2001 Q4 | -2465.40 USD | -426.22% |
| 2001 Q3 | -468.51 USD | 60.12% |
| 2001 Q2 | -1174.93 USD | -448.24% |
| 2001 Q1 | -214.31 USD | 58.33% |
| 2000 Q1 | -240.45 USD | 76.97% |
| 2000 Q2 | -313.93 USD | -30.56% |
| 2000 Q3 | -124.45 USD | 60.36% |
| 2000 Q4 | -514.31 USD | -313.27% |
| 2000 FY | - USD | 92.25% |
| 1999 Q3 | 8.00 USD | 900.0% |
| 1999 Q1 | -6.00 USD | 0.0% |
| 1999 FY | - USD | -136.59% |
| 1999 Q4 | -1044.18 USD | -13152.25% |
| 1999 Q2 | -1.00 USD | 83.33% |
| 1998 FY | - USD | -22842005.26% |
| 1998 Q4 | - USD | 0.0% |
| 1997 FY | - USD | 0.0% |